Dr Andreas WagnerHead Liposome Technology at Polymun Scientific GmbHSpeaker
Profile
Dr Andreas Wagner is Head of Liposome Technology at Polymun Scientific GmbH. He has significant expertise formulation of liposomes and LNPs and development of the respective processes for their clinical use. He and the team at Polymun Scientific have significantly contributed to the 1st successful mRNA vaccine Comirnaty by optimizing and up-scaling the LNP process as well as by supporting clinical and early market supply of the successful Covid-19 vaccine.
Dr Andreas Wagner studied Biotechnology at the University of Applied Life Sciences in Vienna, Austria and earned his Master and Ph.D. degrees in the field of biopharmaceutical technology. Dr Wagner is listed as inventor on multiple patents, like the liposome technology and some product patents of liposomal formulations. Furthermore, he has published several peer reviewed articles dealing with liposomes, the technology, products thereof and their application in preclinical and clinical studies.
Agenda Sessions
Pioneering a Versatile LNP Production Process for mRNA Vaccines, Therapeutics, and Gene Editing - Unveiling the Proof of Concept
, 7:30amView Session